stoxline Quote Chart Rank Option Currency Glossary
  
Tekla Healthcare Investors (HQH)
15.83  0.05 (0.32%)    04-19 16:00
Open: 15.78
High: 15.88
Volume: 137,371
  
Pre. Close: 15.78
Low: 15.78
Market Cap: 765(M)
Technical analysis
2024-04-19 5:10:01 PM
Short term     
Mid term     
Targets 6-month :  19.25 1-year :  19.77
Resists First :  16.48 Second :  16.93
Pivot price 16.19
Supports First :  15.76 Second :  13.11
MAs MA(5) :  15.9 MA(20) :  16.32
MA(100) :  16.59 MA(250) :  16.51
MACD MACD :  -0.3 Signal :  -0.3
%K %D K(14,3) :  10.4 D(3) :  10.2
RSI RSI(14): 33.2
52-week High :  17.78 Low :  14.31
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ HQH ] has closed above bottom band by 14.0%. Bollinger Bands are 6.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 15.89 - 15.97 15.97 - 16.04
Low: 15.59 - 15.68 15.68 - 15.76
Close: 15.7 - 15.83 15.83 - 15.95
Company Description

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Headline News

Tue, 02 Apr 2024
How To Trade (HQH) - Stock Traders Daily

Sat, 23 Mar 2024
(HQH) On The My Stocks Page - Stock Traders Daily

Thu, 21 Mar 2024
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ ... - Kansas City Star

Fri, 27 Oct 2023
abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the ... - Yahoo Finance

Wed, 06 Sep 2023
THQ: Still The Best Of The Tekla Suite (NYSE:THQ) - Seeking Alpha

Sat, 16 Oct 2021
Healthcare Is About To Soar, And These 6%+ Dividends Will Profit - Forbes

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Financial Services
Industry:
Asset Management
Shares Out 49 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 28.2 (%)
Shares Short 15 (K)
Shares Short P.Month 80 (K)
Stock Financials
EPS 1.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 18.84
Profit Margin 547.3 %
Operating Margin -22 %
Return on Assets (ttm) -0.1 %
Return on Equity (ttm) 6 %
Qtrly Rev. Growth 8.1 %
Gross Profit (p.s.) 0
Sales Per Share 0.2
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 14.52
PEG Ratio 0
Price to Book value 0.84
Price to Sales 76.05
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android